MDMA Policy Change

Building Trust at the Edge of Regulation — Shaping the Psychedelic Care Ecosystem in the Netherlands

When a country stands at the threshold of legalizing psychedelic therapy, the challenge isn’t just policy — it’s trust.

SYSTEMIC CHALLENGE

After breakthrough research on MDMA-assisted therapy, the Netherlands faced a pivotal question: how do you act on promising science when public understanding lags behind?

This wasn’t just a regulatory challenge — it was a test of trust, trauma literacy, and ethical pacing.

European Parliament Brussels 25

To navigate it, the Dutch government convened a multidisciplinary State Commission to explore the clinical, legal, and cultural feasibility of regulated psychedelic care.

MY ROLE

I joined the Commission as a clinical psychologist and communications lead, supporting both the design of the research and the tone of its public-facing engagement.

My contributions included:

  • Designing participant surveys with psychological safety built into their structure and sequencing
  • Developing trauma-informed email outreach, which significantly improved response rates and data quality — a change we made after noticing early drop-off due to overly formal language
  • Co-authoring the landmark paper:
    Guiding Policy and Practice: Expert Recommendations for MDMA Therapy in Europe
  • Helping align cross-sector contributors — from scientists and legal advisors to frontline clinicians — around shared language and messaging integrity

As a psychologist, I approached every communications decision not only through a strategic lens, but through clinical insight — attuned to tone, emotional readiness, and the risks of re-traumatization in policy discourse.

BEYOND THE COMMISSION

This work didn’t end at publication — it opened doors and deepened trust:

  • Policy Shift: The Dutch State Commission formally recommended the legalization of MDMA therapy for PTSD — a position directly shaped by the work I supported.
  • Platform Participation: I was invited to join the new European Platform for Regulation of MDMA in Clinical Care as a strategic communications expert — focused on building bridges across clinical, cultural, and ethical lines
  • European Parliament Roundtable: I traveled to Brussels to speak on novel mental health strategies for Ukraine, helping contextualize psychedelic care through the lens of displacement and systemic trauma
ICPR 2024

RESULTS

  • Policy influence: My co-authored paper contributed to a national recommendation to legalize MDMA therapy
  • Cross-national leadership: Invited to guide strategic communications across the European regulatory platform
  • EU-level advocacy: Participated in a high-level roundtable on psychedelic trauma care for displaced populations
  • Community building: Supporting narrative and trust infrastructure across Ukrainian research and mental health communities
  • Storytelling strategy in motion: Designing communications architecture for psychedelic care that is safe, honest, and resonant

 

EXPERTISE IN ACTION

  • Clinical Psychology (Trauma & Psychedelic Readiness)
  • Ethical Communications Strategy
  • Cross-Cultural Research Facilitation
  • Policy-Influence Writing
  • Narrative Design in Emerging Health Systems
  • Ukrainian Mental Health Advocacy in Psychedelic Contexts
Brussels Novel mental Health Treatments Roundtable

REFLECTION

This case isn’t “finished” — and that’s what makes it matter.
I’m not just supporting systems that work. I’m helping build the ones we’ll need next.

Because progress rarely begins with a policy.
Often, it begins with a reworded sentence. A shift in tone.
A single moment when someone feels seen — and responds.

WHAT IS HAPPENING NOW

Later this year, I’ll participate in a MAPS educational program — holding two roles:

  1. Ukrainian clinical psychologist — to deepen my expertise in trauma-sensitive psychedelic care
  2. Communications strategist — to build narrative alignment between Ukrainian psychologists, European policymakers, and the MAPS community

I’ve already designed a storytelling strategy around the program— including long-form articles and social content — and am currently in conversation with MAPS to ensure ethical alignment in how the work is communicated.

STILL IN MOTION

So this isn’t a case study with a clean ending.

It’s a snapshot of real-time systems work — where the metrics aren’t just outcomes, but alignment, traction, and trust.

In fields like psychedelic regulation, trauma care, and cross-cultural mental health, the most meaningful impact rarely arrives as a single win.

It unfolds through tone. Through consensus. Through frameworks that outlast the room.

That’s the kind of work this case study holds: Still in motion. Still earning trust. Still building the future it names.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Add to cart